If the bilirubin of thalassemia minor is not too high, it can be treated without special treatment, and can receive anti-hemolytic drugs and hepatoprotective and choleretic treatment after obvious elevation.
Thalassemia is a hemolytic anemia caused by a disorder of bead protein production.
Hemolysis is the shortening of the life span of red blood cells, easy to rupture, after the rupture of red blood cells will produce a lot of bilirubin, which is beyond the metabolism of the liver and kidneys, so that the bilirubin in the blood rises, with the total bilirubin and indirect bilirubin rising predominantly. Thalassemia patients have different degrees of bilirubin elevation. Attention should be paid to liver protection, weight control, smoking and alcohol cessation, and healthy diet.
Significantly elevated bilirubin can be treated with anti-hemolytic drugs (e.g., aminocaproic acid) and hepatoprotective and choleretic drugs (e.g., ursodeoxycholic acid).
If direct bilirubin is predominantly elevated, accompanied by elevated aminotransferases, epigastric fullness and discomfort, and weight loss, it is necessary to consult a doctor promptly to rule out liver injury, hepatocellular or biliary tract related diseases and treat them promptly.
Thalassemia minor with high bilirubin in all three items is recommended to be treated under the guidance of a specialist, and the above medications should be used under the guidance of a doctor.